BCM
Bayesian Capital Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,130
| Closed | -$138K | – | 623 |
|
|
2025
Q1 | $138K | Sell |
10,130
-8,690
| -46% | -$118K | 0.02% | 523 |
|
|
2024
Q4 | $384K | Buy |
18,820
+10,820
| +135% | +$221K | 0.05% | 433 |
|
|
2024
Q3 | $233K | Sell |
8,000
-42,500
| -84% | -$1.24M | 0.03% | 533 |
|
|
2024
Q2 | $1.17M | Buy |
50,500
+28,700
| +132% | +$666K | 0.13% | 202 |
|
|
2024
Q1 | $447K | Buy |
+21,800
| New | +$447K | 0.04% | 462 |
|
|
2023
Q4 | – | Sell |
-13,942
| Closed | -$288K | – | 819 |
|
|
2023
Q3 | $288K | Buy |
+13,942
| New | +$288K | 0.03% | 477 |
|